Stock Market Analysis

Last week we shared that CEO sentiment was at its highest level in a year. This week we look at further evidence that corporations are feeling more bullish on economic conditions in 2024 than they...

Stock bulls may find it difficult to justify buying stocks at these elevated levels as yields rise. Rising crude oil prices pose additional risk to the inflation outlook. S&P 500 technical...

3M's recent spin-off of its healthcare subsidiary, Solventum Corporation, signals a strategic shift aimed at streamlining its operations and unlocking potential value for shareholders. Despite...

Market breadth is on the rise as 118 S&P 500 stocks hover around their 52-week highs, marking a notable uptrend in the market's performance. Despite the broader market rally, investor interest...

The long-run performance estimate for the Global Market Index (GMI) ticked up again in March vs. the previous month. Today’s revised forecast (based on three models defined below) indicates a...

Culling the weak, but holding the strong.The S&P 500 ended the first quarter of the year on a high note, rising over 10%. Of the magnificent seven, two seem to have dropped out of the running,...

Let's take a look at up to 8 reasons why a dip-buying strategy could be the best way to take advantage of bullish momentum. Meanwhile, gold is benefiting from record central bank buying, apart from...

U.S. jobs report, PMI surveys, Fed speakers will be in focus this week. Fortinet is a buy as its annual ‘Accelerate 2024’ event kicks off. Tesla is a sell with weak Q1 deliveries...

The S&P 500 closed out a blowout month and quarter at a new record high to notch its best start to a year since 2019. Identifying promising opportunities becomes paramount amid the current...

After a sluggish 2023, 2024 looks brighter for healthcare stocks. Numerous demographic and social factors also argue in favor of a long-term rise. What are the best healthcare stocks to buy...

Despite a challenging year with a stock price drop of over 41%, ACADIA Pharmaceuticals is seen by InvestingPro and Wall Street analysts as undervalued, with expectations of significant upside...

Today, we'll explore stocks offering promising dividends alongside potential growth opportunities and market favor. These stocks embody a coveted blend of strong dividends, promising earnings,...

As US index futures hint at a subdued start today amid lingering concerns about stretched valuations, especially on the S&P 500. Awaiting key data releases, investors remain watchful for any...

Nvidia (NASDAQ:NVDA) has been a lightning rod of attention as it surged to parabolic highs over the past several weeks.This surge also helped lead semiconductors stocks higher, along with the Nasdaq...